Posts Comments

Economic Data Saps Sentiment

Economic Data1

      Despite another slew of mostly positive reports from the earnings front, some disappointing economic reports domestically and from China put a wrench in the bulls' plans to extend the recent rally. New home sales fell well short of expectations, manufacturing activity surprisingly slowed, and mortgage applications declined. Moreover, a preliminary read on manufacturing activity in China showed continued contraction, overshadowing a near three-year high in eurozone business activity. Treasuries finished higher following the lackluster data and crude oil prices were … [Read more...]

Here’s the Details on Amazon’s Massive Deal With HBO

This story has been updated from 10:33 am EDT to include comments made by Wedbush Securities Michael Pachter.NEW YORK (TheStreet) - Amazon (AMZN) just one-upped Netflix (NFLX) by announcing a big online content licensing deal with Time Warner's (TWX) HBO. Amazon announced on Wednesday morning that it inked an exclusive multi-year online-only subscription deal for select HBO programming to bring some of its most popular shows to Amazon Prime Members. This is the first time that HBO programming has been licensed to an online-only subscription streaming service, according to the press release. It … [Read more...]

Facebook Earnings: Expect a Bullish Revenue Decline

Updated from 11:28 a.m. ET with year-over-year comps and Wednesday share prices NEW YORK (TheStreet) - Facebook (FB) is expected to post a quarter-over-quarter drop in total advertising revenue as the growth rate of the company's costs per impressions (CPM's) decline. If slowing engagement and declining ad revenue sound worrying, bullish Facebook analysts seem to have found a way to rationalize it. Facebook, according to multiple Wall Street analysts, may be in the process of a long-term change to its advertising business that could undermine first quarter results but provide a long-term … [Read more...]

5 College Debt Myths You Can’t Afford to Believe

NEW YORK (TheStreet) -- The end of April signals a big decision for millions of high school seniors: What college or university will they call home for the next four years? In most cases, their parents will have a big say, as in many cases they'll be paying for that college education. It's also a big time of year for graduating college seniors, who'll enter the "real world" and start paying back their student loans. Both groups -- high school and college seniors -- will need all the help they can get in dealing with increasingly burdensome student loan debt. According to the Project on … [Read more...]

May Crude Oil Ends At Two-week Low Expiration Day

SAN FRANCISCO –  Oil futures ended sharply lower on Tuesday, with the May contract losing more than 2% to settle at a two-week low on its expiration day. May crude fell $2.24, or 2.2%, to settle at $102.13 a barrel on the New York Mercantile Exchange, the contract's lowest settlement since April 7. June crude , which is now the front-month contract, settled at $101.75 a barrel, down $1.90, or 1.8%. Copyright © 2014 MarketWatch, Inc. … [Read more...]

Valeant won’t pay whatever it takes for Allergan: CEO

Valeant Pharmaceuticals Inc won't pay whatever it takes to acquire rival Allergan Inc, and it will not turn its bid into an all-cash deal, Valeant Chief Executive Michael Pearson said on Tuesday in New York. Valeant and activist investor Bill Ackman made an unsolicited $47 billion bid to buy Botox maker Allergan as it seeks to become one of the world's five biggest drug companies. (Reporting by Bill Berkrot in New York; Writing by Rod Nickel in Winnipeg, Manitoba; Editing by Meredith Mazzilli) … [Read more...]

M&A and Earnings Keep Winning Streak Alive


    The S&P 500 is poised for a sixth-straight session of gains with stocks finding support from some massive M&A announcements in the pharmaceuticals sector, as well as a plethora of mostly better-than-expected earnings reports. Novartis AG, GlaxoSmithKline Plc, and Eli Lilly and Co announced a series of deals for a total of $28.5 billion, while Valeant Pharmaceuticals International announced a proposed merger with Allergan valued at over $45.0 billion. Meanwhile, Netflix, and Dow members Travelers Companies and United Technologies all topped the Street's profit … [Read more...]

Why Facebook Just Got Upgraded

Updated from 10:47 a.m. to include additional information about WhatsApp. NEW YORK (TheStreet) -- Ahead of earnings on Wednesday, Facebook (FB) is getting a boost, as one analyst believes the company's earnings power is being severely unappreciated by Wall Street. Credit Suisse analyst Stephen Ju upgraded shares to "outperform" from "neutral," raising his price target to $87 from $65, as he believes the company can earn vastly more from its 1.2 billion users with a combination of existing products and future ones. "Our point of differentiation with this report is in the explicit … [Read more...]

Why Tesla Motors Stock Is Higher This Morning

NEW YORK (TheStreet) -- Shares of Tesla Motors (TSLA) are up 2.43% to $209.34 in early trade today. In Beijing, CEO Elon Musk said that Panasonic Corp.  (PCRFY) will likely be his company's partner in a planned $5 billion U.S. battery factory, and that the electric car maker would release details in two or three months, the Wall Street Journal reports. Panasonic said nothing has been decided as yet. Must Read: Warren Buffett's 10 Favorite Growth Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. … [Read more...]

How to Trade Wednesday’s Earnings Including Boeing, Procter & Gamble

NEW YORK (TheStreet) -- Boeing (BA) and Procter & Gamble (PG) headline a parade of large-cap companies reporting earnings before the bell Wednesday. Today we'll profile these companies' stocks, providing you with information on how to trade them.When we profile stocks before earnings we include two "Crunching the Numbers" tables (see Pages 3 and 4). The first table covers technical analysis. The second table covers analysts' earnings per share estimates and where to buy on weakness and sell on strength. Let's start with individual profiles and then look at the tables. Boeing ($127.82, down … [Read more...]